SAFION 50 TAB

About

Safion 50 mg tablets contain Safinamide, a novel medication used as an add-on therapy for Parkinson's disease. It functions primarily as a selective and reversible monoamine oxidase B (MAO-B) inhibitor, which prevents the breakdown of dopamine in the brain, thereby increasing dopamine levels and prolonging its effects. Additionally, safinamide has non-dopaminergic actions, including modulation of glutamate release and blockade of voltage-sensitive sodium channels, which may contribute to its neuroprotective and anti-dyskinetic properties. By enhancing dopaminergic neurotransmission and potentially offering neuroprotection, Safinamide helps to improve motor symptoms and reduce "off" time in patients experiencing motor fluctuations on levodopa therapy, providing a significant advancement in the management of advanced Parkinson's disease.

Uses

• Adjunctive treatment for Parkinson's disease.
• Used in patients experiencing "off" episodes on levodopa therapy.
• Helps improve motor symptoms in Parkinson's disease.
• Reduces daily "off" time in advanced Parkinson's disease.

Directions For Use

Take Safion tablets orally once daily, with or without food, at the same time each day, as directed by your doctor.

Benefits

• Reduces "off" time in Parkinson's disease patients.
• Improves motor symptoms like tremor, rigidity, and bradykinesia.
• Enhances the effects of levodopa therapy.
• Offers a selective and reversible MAO-B inhibition.
• May have neuroprotective properties.
• Convenient once-daily dosing.

Side Effects

• Dyskinesia (involuntary movements)
• Nausea
• Insomnia
• Dizziness
• Headache
• Orthostatic hypotension
• Falls
• Arthralgia (joint pain)
• Cough
• Hypertension
• Hallucinations
• Anxiety

Safety Measures

• Alcohol - Avoid excessive alcohol consumption as it can exacerbate CNS side effects like dizziness and drowsiness.
• Pregnancy - There is limited data on safinamide use in pregnant women. Animal studies show reproductive toxicity. Use only if the potential benefit justifies the potential risk to the fetus. Consult your doctor.
• Breastfeeding - It is unknown if safinamide is excreted in human milk. Due to potential serious adverse reactions in breastfed infants, a decision should be made whether to discontinue nursing or the drug, considering the importance of the drug to the mother.
• Liver - Safinamide is primarily metabolized in the liver. Dose adjustment is required for patients with moderate hepatic impairment. It is contraindicated in patients with severe hepatic impairment.
• Kidney - No dose adjustment is required for patients with mild to moderate renal impairment. Use with caution in severe renal impairment as data are limited.
• Lung - No specific direct lung effects are commonly associated with safinamide. However, general caution is advised in patients with severe respiratory conditions due to potential CNS effects.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.